Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity
Authors
Keywords
chloroethylnitrosoureas, tumor targeting, hypoxia-activated prodrug, DNA interstrand crosslinks, drug resistance, O, -alkylguanine DNA alkyltransferase
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 144, Issue -, Pages 112338
Publisher
Elsevier BV
Online
2021-10-22
DOI
10.1016/j.biopha.2021.112338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
- (2020) Somshuvra Bhattacharya et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
- (2020) Fabrizio Fontana et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
- (2020) Bárbara Pinto et al. Pharmaceutics
- DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
- (2019) Bernd Kaina et al. DNA REPAIR
- An azobenzene-based heteromeric prodrug for hypoxia-activated chemotherapy by regulating subcellular localization
- (2018) Shiying Li et al. CHEMICAL COMMUNICATIONS
- The specific role of O6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy
- (2018) Guohui Sun et al. Future Medicinal Chemistry
- NBGNU: a hypoxia-activated tripartite combi-nitrosourea prodrug overcoming AGT-mediated chemoresistance
- (2018) Yao Ge et al. Future Medicinal Chemistry
- Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU
- (2017) Yameng Wang et al. ACS Medicinal Chemistry Letters
- Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O6-alkylguanine-DNA alkyltransferase
- (2016) Guohui Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
- (2016) Christine Jungk et al. BMC CANCER
- Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma
- (2016) Y. Qin et al. MOLECULAR CANCER THERAPEUTICS
- Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking
- (2016) Guohui Sun et al. MOLECULES
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Investigations on the Effect of O6-Benzylguanine on the Formation of dG-dC Interstrand Cross-Links Induced by Chloroethylnitrosoureas in Human Glioma Cells Using Stable Isotope Dilution High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry
- (2014) Guohui Sun et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
- (2014) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantification of DNA interstrand crosslinks induced by ACNU in NIH/3T3 and L1210 cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry
- (2014) Lili Li et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM
- (2013) Stephen J. Florczyk et al. BIOMATERIALS
- Quantitation of Pyridyloxobutyl-DNA Adducts in Tissues of Rats Treated Chronically with (R)- or (S)-N′-Nitrosonornicotine (NNN) in a Carcinogenicity Study
- (2013) Lijiao Zhao et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Advances in the development of hybrid anticancer drugs
- (2013) Sébastien Fortin et al. Expert Opinion on Drug Discovery
- Synthesis of trans- and cis-4′-Hydroxylomustine and Development of Validated Analytical Method for Lomustine and trans- and cis-4′-Hydroxylomustine in Canine Plasma
- (2013) L. Dirikolu et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Hypoxia-Selective O6-Alkylguanine-DNA Alkyltransferase Inhibitors: Design, Synthesis, and Evaluation of 6-(Benzyloxy)-2-(aryldiazenyl)-9H-purines as Prodrugs of O6-Benzylguanine
- (2013) Rui Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- EO9 (Apaziquone): from the clinic to the laboratory and back again
- (2012) Roger M Phillips et al. BRITISH JOURNAL OF PHARMACOLOGY
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- Chloroethylnitrosourea-induced cell death and genotoxicity: Cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ
- (2012) Teodora Nikolova et al. CELL CYCLE
- A density functional theory investigation on the formation mechanisms of DNA interstrand crosslinks induced by chloroethylnitrosoureas
- (2012) Li-Jiao Zhao et al. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
- Comparative theoretical investigation of the formation of DNA interstrand crosslinks induced by two kinds ofN-nitroso compounds: nitrosoureas and nitrosamines
- (2012) Lijiao Zhao et al. JOURNAL OF PHYSICAL ORGANIC CHEMISTRY
- Multifaceted Roles of Alkyltransferase and Related Proteins in DNA Repair, DNA Damage, Resistance to Chemotherapy, and Research Tools
- (2011) Anthony E. Pegg CHEMICAL RESEARCH IN TOXICOLOGY
- A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
- (2011) Katherine E. Warren et al. JOURNAL OF NEURO-ONCOLOGY
- Mechanisms of neurotoxicity induced in the developing brain of mice and rats by DNA-damaging chemicals
- (2011) Kunio Doi JOURNAL OF TOXICOLOGICAL SCIENCES
- Selection of genetically modified hematopoietic cells in vitro and in vivo using alkylating agent lysomustine
- (2010) F.N. Rozov et al. ANALYTICAL BIOCHEMISTRY
- Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors
- (2010) K. O. Hicks et al. CLINICAL CANCER RESEARCH
- DNA interstrand crosslink repair in mammalian cells: step by step
- (2009) Parameswary A Muniandy et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- LC−MS/MS for the Detection of DNA Interstrand Cross-Links Formed by 8-Methoxypsoralen and UVA Irradiation in Human Cells
- (2008) Huachuan Cao et al. ANALYTICAL CHEMISTRY
- DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response
- (2008) William J. Bodell JOURNAL OF NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now